How Tirzepatide Works Tirzepatide's dual agonism creates synergistic metabolic effects: GIP receptor activation enhances insulin secretion and may improve fat metabolism GLP-1 receptor activation suppresses glucagon, slows gastric emptying, and reduces appetite Combined pathway stimulation produces greater metabolic benefits than single-pathway agonists Dose-dependent effects allow for personalized titration based on individual response The dual mechanism explains why tirzepatide has demonstrated superior weight loss outcomes compared to single GLP-1 agonists in head-to-head clinical trials
9b), ETC complex expression (CIII, CI
Exceptional Access Program (EAP) The EAP facilitates access to drugs not funded through the ODB Formulary, or where no listed alternative is available
Typical doses run 600-1200mg for general wellness and 1000-1200mg for skin treatments
Administered through various routes such as injections, oral ingestion, and topical applications, therapeutic peptides have shown remarkable efficacy in reducing inflammation, improving wound healing, and enhancing physical activity
The medication mimics your natural GLP-1 peptide hormone, making you feel satisfied after a meal and have fewer cravings